Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation (Q47593295)
Jump to navigation
Jump to search
scientific article published in October 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation |
scientific article published in October 2003 |
Statements
1 reference
Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation (English)
1 reference
1 reference
1 reference
1 reference
Voena C
1 reference
Malnati M
1 reference
Majolino I
1 reference
Fagà G
1 reference
Santoro A
1 reference
Ladetto M
1 reference
Boccadoro M
1 reference
1 October 2003
1 reference
1 reference
32
1 reference
8
1 reference
791-793
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference